CARE Ratings Shows Positive Performance in Q2 FY25 Financial Results

Oct 23 2024 09:01 PM IST
share
Share Via
CARE Ratings, a leading smallcap ratings agency, has reported a positive performance in its financial results for the quarter ending September 2024. The company's operating cash flow and net sales have shown consistent growth, while its operating profit margin and profitability have also improved. However, the dividend payout ratio remains a concern.

CARE Ratings, a leading ratings agency in the smallcap industry, has recently declared its financial results for the quarter ending September 2024. The company has shown a positive performance with a score of 17, which is an improvement from the previous score of 8 in the last three months.

One of the key factors contributing to this positive performance is the company’s strong operating cash flow, which has been consistently growing over the last three years. In the last five quarters, CARE Ratings has also seen a significant increase in its net sales, with the highest recorded at Rs 117.37 crore. This indicates a positive trend in the company’s sales performance.


Furthermore, CARE Ratings has also shown a strong operating profit margin of 47.47%, which is the highest in the last five quarters. This reflects the company’s improved efficiency in managing its operations. In terms of profitability, the company has also seen a growth in its profit before tax (PBT) and profit after tax (PAT) by 34.73% and 31.0% respectively, compared to the same quarter last year.


However, one area of concern for CARE Ratings is its dividend payout ratio, which has been consistently low at 53.45% in the last five years. This indicates that the company is distributing a lower proportion of its profits as dividends to its shareholders.


Overall, the financial results for the quarter ending September 2024 show a positive trend for CARE Ratings, with strong performance in key areas such as operating cash flow, net sales, and profitability. Investors are advised to hold their stock, as recommended by MarketsMOJO, and keep an eye on the company’s future performance.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News